Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
SkinHealth Systems Inc. reported the fiscal year ended December 31, 2023 results: revenue $398.0 million, net income $(100.1) million.
- Period
- the fiscal year ended December 31, 2023
- Revenue
- $398.0 million
- Net income
- $(100.1) million
- Result
- reported results
Exact text from the filing
with its disclosure obligations under Regulation FD. --- EX-99.1 (EX-99.1) --- BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results Delivers net sales of $398 million for the full year and $96.8 million for the fourth quarter driven by growth across international markets Long Beach, Calif., March 12, 2024 – The Beauty Health Company (NASDAQ:
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
SkinHealth Systems Inc. reported the fourth quarter ended December 31, 2023 results: revenue $96.8 million, net income $(9.4) million.
- Period
- the fourth quarter ended December 31, 2023
- Revenue
- $96.8 million
- Net income
- $(9.4) million
- Result
- reported results
Exact text from the filing
Regulation FD. --- EX-99.1 (EX-99.1) --- BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results Delivers net sales of $398 million for the full year and $96.8 million for the fourth quarter driven by growth across international markets Long Beach, Calif., March 12, 2024 – The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth”), home to
View on SEC.gov